Medtronic plc (NYSE: MDT) reported fourth quarter 2023 earnings results today.
Revenue was $8.5 billion, up 5.6% year-over-year, both on a reported and organic basis.
On a GAAP basis, net income decreased 21% to $1.179 billion while EPS dropped 20% to $0.88, compared to last year. Adjusted EPS of $1.57 increased 3% YoY.
For FY2024, organic revenue is expected to grow 4.0-4.5% while adjusted EPS is projected to be $5.00-5.10.
Prior performance
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
